{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:57:09Z","timestamp":1790985429356,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special project of integrated traditional and Western medicine in Shanghai General Hospital in China","award":["ZHYY-ZXYJHZX-202104"],"award-info":[{"award-number":["ZHYY-ZXYJHZX-202104"]}]},{"name":"the Key Discipline Construction Project of Shanghai Xuhui Health System","award":["SHXHZDXK202322"],"award-info":[{"award-number":["SHXHZDXK202322"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03692-9","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:42:52Z","timestamp":1735278172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Fangfang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"10","key":"3692_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/toxins13100677","volume":"13","author":"N Ahmad-Mansour","year":"2021","unstructured":"Ahmad-Mansour N, Loubet P, Pouget C, et al. Staphylococcus aureus Toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel). 2021;13(10):677. https:\/\/doi.org\/10.3390\/toxins13100677. Published 2021 Sep 23.","journal-title":"Toxins (Basel)"},{"issue":"7","key":"3692_CR2","doi-asserted-by":"publisher","first-page":"e00932","DOI":"10.1128\/IAI.00932-19","volume":"88","author":"KL Urish","year":"2020","unstructured":"Urish KL, Cassat JE. Staphylococcus aureus Osteomyelitis: bone, bugs, and surgery. Infect Immun. 2020;88(7):e00932\u201319. https:\/\/doi.org\/10.1128\/IAI.00932-19. Published 2020 Jun 22.","journal-title":"Infect Immun"},{"issue":"4","key":"3692_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/toxins13040287","volume":"13","author":"B L\u00f6ffler","year":"2021","unstructured":"L\u00f6ffler B, Tuchscherr L. Staphylococcus aureus Toxins: promoter or handicap during infection? Toxins (Basel). 2021;13(4):287. https:\/\/doi.org\/10.3390\/toxins13040287. Published 2021 Apr 19.","journal-title":"Toxins (Basel)"},{"issue":"6","key":"3692_CR4","doi-asserted-by":"publisher","first-page":"e39996","DOI":"10.7759\/cureus.39996","volume":"15","author":"E Henriquez","year":"2023","unstructured":"Henriquez E, Fatima N, Sayabugari R, et al. Transesophageal Echocardiography vs. Transthoracic Echocardiography for Methicillin-Sensitive Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Endocarditis. Cureus. 2023;15(6):e39996. https:\/\/doi.org\/10.7759\/cureus.39996. Published 2023 Jun 5.","journal-title":"Cureus"},{"issue":"8","key":"3692_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3760\/cma.j.cn112150-20190819-00669","volume":"54","author":"TY Chen","year":"2020","unstructured":"Chen TY, Ge YL, Liu XW, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(8):849\u201353. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20190819-00669","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"Suppl 1","key":"3692_CR6","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1093\/cid\/ciaa1591","volume":"72","author":"RE Nelson","year":"2021","unstructured":"Nelson RE, Goto M, Samore MH, et al. Expanding an economic evaluation of the Veterans affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of infections from other pathogens. Clin Infect Dis. 2021;72(Suppl 1):S50\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa1591","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3692_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4014\/jmb.2301.01004","volume":"33","author":"SY Yi","year":"2023","unstructured":"Yi SY, Jeong J, Lee WS, Kwon J, Yoon K, Park K. A simple and Rapid Methicillin-Resistant Staphylococcus aureus (MRSA) Screening Test using a mannose-binding lectin (MBL)-Conjugated gold nanoparticle probe. J Microbiol Biotechnol. 2023;33(5):698\u2013705. https:\/\/doi.org\/10.4014\/jmb.2301.01004","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"3692_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/sur.2020.293","volume":"22","author":"IH Chen","year":"2021","unstructured":"Chen IH, Silberg BN, Nicolau DP. Bactericidal in vitro activity of a tissue-achievable concentration of Cefazolin against Methicillin-Resistant Staphylococcus aureus. Surg Infect (Larchmt). 2021;22(4):447\u20139. https:\/\/doi.org\/10.1089\/sur.2020.293","journal-title":"Surg Infect (Larchmt)"},{"issue":"12","key":"3692_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.4014\/jmb.2208.08004","volume":"32","author":"AE Abo-Amer","year":"2022","unstructured":"Abo-Amer AE, Gad El-Rab SMF, Halawani EM, Niaz AM, Bamaga MS. Prevalence and molecular characterization of Methicillin-Resistant Staphylococcus aureus from nasal specimens: overcoming MRSA with Silver nanoparticles and their applications. J Microbiol Biotechnol. 2022;32(12):1537\u201346. https:\/\/doi.org\/10.4014\/jmb.2208.08004","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"3692_CR10","doi-asserted-by":"publisher","first-page":"103604","DOI":"10.1016\/j.sjbs.2023.103604","volume":"30","author":"B Ali Alghamdi","year":"2023","unstructured":"Ali Alghamdi B, Al-Johani I, Al-Shamrani JM, et al. Antimicrobial resistance in methicillin-resistant staphylococcus aureus. Saudi J Biol Sci. 2023;30(4):103604. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103604","journal-title":"Saudi J Biol Sci"},{"key":"3692_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"RJ Fair","year":"2014","unstructured":"Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25\u201364. https:\/\/doi.org\/10.4137\/PMC.S14459. Published 2014 Aug 28.","journal-title":"Perspect Medicin Chem"},{"issue":"10","key":"3692_CR12","doi-asserted-by":"publisher","first-page":"e18925","DOI":"10.7759\/cureus.18925","volume":"13","author":"S Unni","year":"2021","unstructured":"Unni S, Siddiqui TJ, Bidaisee S. Reduced susceptibility and resistance to Vancomycin of Staphylococcus aureus: a review of global incidence patterns and related genetic mechanisms. Cureus. 2021;13(10):e18925. https:\/\/doi.org\/10.7759\/cureus.18925. Published 2021 Oct 20.","journal-title":"Cureus"},{"issue":"1","key":"3692_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12941-023-00621-y","volume":"22","author":"K Khoothiam","year":"2023","unstructured":"Khoothiam K, Prapasawat W, Yosboonruang A, et al. Prevalence, antimicrobial resistance, and enterotoxin gene profiles of Staphylococcus aureus isolated from mobile phones of the food vendors in Phayao Province, Thailand. Ann Clin Microbiol Antimicrob. 2023;22(1):68. https:\/\/doi.org\/10.1186\/s12941-023-00621-y. Published 2023 Aug 7.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"20","key":"3692_CR14","doi-asserted-by":"publisher","first-page":"115697","DOI":"10.1016\/j.bmc.2020.115697","volume":"28","author":"D Jia","year":"2020","unstructured":"Jia D, Dou Y, Li Z, et al. Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis. Bioorg Med Chem. 2020;28(20):115697. https:\/\/doi.org\/10.1016\/j.bmc.2020.115697","journal-title":"Bioorg Med Chem"},{"key":"3692_CR15","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.jep.2021.114542","volume":"281","author":"M Zhu","year":"2021","unstructured":"Zhu M, Wang ZJ, He YJ, et al. Bioguided isolation, identification and bioactivity evaluation of anti-MRSA constituents from Morus alba Linn. J Ethnopharmacol. 2021;281:114542. https:\/\/doi.org\/10.1016\/j.jep.2021.114542","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3692_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5582\/bst.2015.01019","volume":"9","author":"F Qi","year":"2015","unstructured":"Qi F, Zhao L, Zhou A, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9(1):16\u201334. https:\/\/doi.org\/10.5582\/bst.2015.01019","journal-title":"Biosci Trends"},{"key":"3692_CR17","doi-asserted-by":"publisher","first-page":"109543","DOI":"10.1016\/j.biopha.2019.109543","volume":"120","author":"C Liu","year":"2019","unstructured":"Liu C, Yang S, Wang K, et al. Alkaloids from traditional Chinese medicine against hepatocellular carcinoma. Biomed Pharmacother. 2019;120:109543. https:\/\/doi.org\/10.1016\/j.biopha.2019.109543","journal-title":"Biomed Pharmacother"},{"key":"3692_CR18","doi-asserted-by":"publisher","first-page":"106602","DOI":"10.1016\/j.ejps.2023.106602","volume":"191","author":"X Li","year":"2023","unstructured":"Li X, Ma Z, Tang Q, et al. 8-octyl berberine combats Staphylococcus aureus by preventing peptidoglycan synthesis. Eur J Pharm Sci. 2023;191:106602. https:\/\/doi.org\/10.1016\/j.ejps.2023.106602","journal-title":"Eur J Pharm Sci"},{"key":"3692_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fphar.2016.00362","volume":"7","author":"HL Tan","year":"2016","unstructured":"Tan HL, Chan KG, Pusparajah P, et al. Rhizoma Coptidis: a potential Cardiovascular Protective Agent. Front Pharmacol. 2016;7:362. https:\/\/doi.org\/10.3389\/fphar.2016.00362. Published 2016 Oct 7.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3692_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.22038\/IJBMS.2017.8682","volume":"20","author":"J Tabeshpour","year":"2017","unstructured":"Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017;20(5):557\u201368. https:\/\/doi.org\/10.22038\/IJBMS.2017.8682","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"3692_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/aps.2016.125","volume":"38","author":"K Zou","year":"2017","unstructured":"Zou K, Li Z, Zhang Y, et al. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38(2):157\u201367. https:\/\/doi.org\/10.1038\/aps.2016.125","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"3692_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CAD.0000000000000835","volume":"31","author":"C Gong","year":"2020","unstructured":"Gong C, Hu X, Xu Y, et al. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78. Anticancer Drugs. 2020;31(2):141\u20139. https:\/\/doi.org\/10.1097\/CAD.0000000000000835","journal-title":"Anticancer Drugs"},{"issue":"11","key":"3692_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/labinvest.2017.71","volume":"97","author":"D Li","year":"2017","unstructured":"Li D, Zhang Y, Liu K, et al. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth. Lab Invest. 2017;97(11):1343\u201353. https:\/\/doi.org\/10.1038\/labinvest.2017.71","journal-title":"Lab Invest"},{"issue":"6","key":"3692_CR24","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/med.21703","volume":"40","author":"XF Shang","year":"2020","unstructured":"Shang XF, Yang CJ, Morris-Natschke SL, et al. Biologically active isoquinoline alkaloids covering 2014\u20132018. Med Res Rev. 2020;40(6):2212\u201389. https:\/\/doi.org\/10.1002\/med.21703","journal-title":"Med Res Rev"},{"issue":"6","key":"3692_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s10787-022-01080-1","volume":"30","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, et al. The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology. 2022;30(6):2003\u201316. https:\/\/doi.org\/10.1007\/s10787-022-01080-1","journal-title":"Inflammopharmacology"},{"issue":"11","key":"3692_CR26","doi-asserted-by":"publisher","first-page":"10885","DOI":"10.1007\/s11033-022-07623-7","volume":"49","author":"N Nourizadeh","year":"2022","unstructured":"Nourizadeh N, Vazifeh Mostaan L, Saburi E, Hashemy SI. Modulatory effect of berberine on plasma lipoprotein (or lipid) profile: a review. Mol Biol Rep. 2022;49(11):10885\u201393. https:\/\/doi.org\/10.1007\/s11033-022-07623-7","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3692_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00253-012-4302-y","volume":"96","author":"WJ Kong","year":"2012","unstructured":"Kong WJ, Xing XY, Xiao XH, et al. Effect of berberine on Escherichia coli, Bacillus subtilis, and their mixtures as determined by isothermal microcalorimetry. Appl Microbiol Biotechnol. 2012;96(2):503\u201310. https:\/\/doi.org\/10.1007\/s00253-012-4302-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7","key":"3692_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Han Y, Huang W, Jin M, Gao Z. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021;11(7):1789\u2013812. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.013","journal-title":"Acta Pharm Sin B"},{"key":"3692_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3762\/bjnano.13.56","volume":"13","author":"HT Nguyen","year":"2022","unstructured":"Nguyen HT, Pham TN, Le AT, Thuy NT, Huy TQ, Nguyen TTT. Antibacterial activity of a berberine nanoformulation. Beilstein J Nanotechnol. 2022;13:641\u201352. https:\/\/doi.org\/10.3762\/bjnano.13.56. Published 2022 Jul 11.","journal-title":"Beilstein J Nanotechnol"},{"key":"3692_CR30","doi-asserted-by":"publisher","unstructured":"Wu S, Yang K, Hong Y et al. A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureus Revealed by Untargeted Metabolomic Studies. Front Microbiol. 2022;13:917414. Published 2022 Jul 13. https:\/\/doi.org\/10.3389\/fmicb.2022.917414","DOI":"10.3389\/fmicb.2022.917414"},{"issue":"5","key":"3692_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","volume":"14","author":"D Song","year":"2020","unstructured":"Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med. 2020;14(5):564\u201382. https:\/\/doi.org\/10.1007\/s11684-019-0724-6","journal-title":"Front Med"},{"issue":"1","key":"3692_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12866-020-02003-2","volume":"20","author":"X Li","year":"2020","unstructured":"Li X, Wang P, Hu X, et al., et al. The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and Vancomycin-intermediate Staphylococcus aureus. BMC Microbiol. 2020;20(1):317. https:\/\/doi.org\/10.1186\/s12866-020-02003-2. Published 2020 Oct 19.","journal-title":"BMC Microbiol"},{"key":"3692_CR33","doi-asserted-by":"publisher","unstructured":"Chu M, Zhang MB, Liu YC et al. Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Sci Rep. 2016;6:24748. Published 2016 Apr 22. https:\/\/doi.org\/10.1038\/srep24748","DOI":"10.1038\/srep24748"},{"key":"3692_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","volume":"34","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C. Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021;34:43\u201363. https:\/\/doi.org\/10.1016\/j.jare.2021.06.023. Published 2021 Jul 6.","journal-title":"J Adv Res"},{"key":"3692_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejpb.2022.09.002","volume":"179","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen X, Li D, et al. Platensimycin-berberine chloride co-amorphous drug system: sustained release and prolonged half-life. Eur J Pharm Biopharm. 2022;179:126\u201336. https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.002","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3692_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1021\/acs.jmedchem.1c01592","volume":"65","author":"H Sun","year":"2022","unstructured":"Sun H, Huang SY, Jeyakkumar P, Cai GX, Fang B, Zhou CH. Natural berberine-derived Azolyl Ethanols as New Structural Antibacterial agents against Drug-Resistant Escherichia coli. J Med Chem. 2022;65(1):436\u201359. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01592","journal-title":"J Med Chem"},{"key":"3692_CR37","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2147\/IDR.S357077","volume":"15","author":"S Xia","year":"2022","unstructured":"Xia S, Ma L, Wang G, et al. Vitro vitro Antimicrobial ActivitymechanismMechanism of Bagainste Against Methicillin-Resistant Staphylococcuisolated IsolabloodstreamoinfectionIpatients Patients. Infect Drug Resist. 2022;15:1933\u201344. https:\/\/doi.org\/10.2147\/IDR.S357077. Published 2022 Apr 19.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"3692_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2174\/1568026620666201022144405","volume":"21","author":"A Baska","year":"2021","unstructured":"Baska A, Leis K, Ga\u0142\u0105zka P. Berberine in the treatment of diabetes Mellitus: a review. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1379\u201386. https:\/\/doi.org\/10.2174\/1568026620666201022144405","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"3692_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/metabo13010096","volume":"13","author":"LF Laurindo","year":"2023","unstructured":"Laurindo LF, Santos AROD, Carvalho ACA, et al. Phytochemicals and regulation of NF-kB in Inflammatory Bowel diseases: an overview of in vitro and in vivo effects. Metabolites. 2023;13(1):96. https:\/\/doi.org\/10.3390\/metabo13010096. Published 2023 Jan 7.","journal-title":"Metabolites"},{"key":"3692_CR40","doi-asserted-by":"publisher","unstructured":"Sokolov S, Zyrina A, Akimov S, Knorre D, Severin F. Toxic Effects of Penetrating Cations. Membranes (Basel). 2023;13(10):841. Published 2023 Oct 22. https:\/\/doi.org\/10.3390\/membranes13100841","DOI":"10.3390\/membranes13100841"},{"key":"3692_CR41","doi-asserted-by":"publisher","unstructured":"Zhang C, Li Z, Pan Q, et al. Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus. Microbiol (Reading). 2022;168(9). https:\/\/doi.org\/10.1099\/mic.0.001243","DOI":"10.1099\/mic.0.001243"},{"key":"3692_CR42","doi-asserted-by":"publisher","unstructured":"Attallah NGM, Al-Fakhrany OM, Elekhnawy E et al. Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, in vitro, and in vivo Approaches. Antibiotics (Basel). 2022;11(8):993. Published 2022 Jul 24. https:\/\/doi.org\/10.3390\/antibiotics11080993","DOI":"10.3390\/antibiotics11080993"},{"key":"3692_CR43","doi-asserted-by":"publisher","unstructured":"Chen Y, Li K, Zhao H et al. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia. J Transl Med. 2022;20(1):412. Published 2022 Sep 8. https:\/\/doi.org\/10.1186\/s12967-022-03623-0","DOI":"10.1186\/s12967-022-03623-0"},{"key":"3692_CR44","doi-asserted-by":"publisher","first-page":"153881","DOI":"10.1016\/j.phymed.2021.153881","volume":"96","author":"JH Fan","year":"2022","unstructured":"Fan JH, Xu MM, Zhou LM, et al. Integrating network pharmacology deciphers the action mechanism of Zuojin capsule in suppressing colorectal cancer. Phytomedicine. 2022;96:153881. https:\/\/doi.org\/10.1016\/j.phymed.2021.153881","journal-title":"Phytomedicine"},{"issue":"1","key":"3692_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s10020-021-00414-z","volume":"27","author":"Y Tang","year":"2021","unstructured":"Tang Y, Su H, Wang H, et al. The effect and mechanism of Jiao-Tai-Wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis. Mol Med. 2021;27(1):154. https:\/\/doi.org\/10.1186\/s10020-021-00414-z. Published 2021 Dec 7.","journal-title":"Mol Med"},{"key":"3692_CR46","doi-asserted-by":"publisher","unstructured":"Akram FE, El-Tayeb T, Abou-Aisha K, El-Azizi M. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). Ann Clin Microbiol Antimicrob. 2016;15(1):48. Published 2016 Aug 17. https:\/\/doi.org\/10.1186\/s12941-016-0164-y","DOI":"10.1186\/s12941-016-0164-y"},{"issue":"5","key":"3692_CR47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1021\/acschemneuro.1c00439","volume":"13","author":"C Fu","year":"2022","unstructured":"Fu C, Shuang Q, Liu Y, Zeng L, Su W. Baihe extracts reduce the activation and apoptosis of Microglia in the Hippocampus of mice with Depression-like behaviors by Downregulating MYC. ACS Chem Neurosci. 2022;13(5):587\u201398. https:\/\/doi.org\/10.1021\/acschemneuro.1c00439","journal-title":"ACS Chem Neurosci"},{"issue":"13","key":"3692_CR48","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.18632\/aging.204868","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang M, Zhu J, Ye Y, Li P, Sun W, Zhang M. N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer. Aging. 2023;15(13):6526\u201344. https:\/\/doi.org\/10.18632\/aging.204868","journal-title":"Aging"},{"issue":"11","key":"3692_CR49","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.7150\/jca.85517","volume":"14","author":"C Gu","year":"2023","unstructured":"Gu C, Tang L, Hao Y, et al. Network pharmacology and bioinformatics were used to construct a prognostic model and immunoassay of core target genes in the combination of quercetin and kaempferol in the treatment of colorectal cancer. J Cancer. 2023;14(11):1956\u201380. https:\/\/doi.org\/10.7150\/jca.85517. Published 2023 Jul 3.","journal-title":"J Cancer"},{"key":"3692_CR50","doi-asserted-by":"publisher","first-page":"3276156","DOI":"10.1155\/2019\/3276156","volume":"2019","author":"S Wu","year":"2019","unstructured":"Wu S, Liu Y, Zhang H, Lei L. The pathogenicity and Transcriptome Analysis of Methicillin-Resistant Staphylococcus aureus in response to Water Extract of Galla Chinensis. Evid Based Complement Alternat Med. 2019;2019:3276156. https:\/\/doi.org\/10.1155\/2019\/3276156. Published 2019 Jul 16.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"3692_CR51","doi-asserted-by":"publisher","first-page":"e68053","DOI":"10.1371\/journal.pone.0068053","volume":"8","author":"X Lu","year":"2013","unstructured":"Lu X, Yang X, Li X, et al. Vitro vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus. PLoS ONE. 2013;8(7):e68053. https:\/\/doi.org\/10.1371\/journal.pone.0068053. Published 2013 Jul 2.","journal-title":"PLoS ONE"},{"issue":"11","key":"3692_CR52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/s0024-3205(03)00435-1","volume":"73","author":"DU Lee","year":"2003","unstructured":"Lee DU, Kang YJ, Park MK, et al. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 2003;73(11):1401\u201312. https:\/\/doi.org\/10.1016\/s0024-3205(03)00435-1","journal-title":"Life Sci"},{"issue":"7","key":"3692_CR53","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/pharmaceutics15071782","volume":"15","author":"T Zheng","year":"2023","unstructured":"Zheng T, Chen H, Wu C, et al. Fabrication of Co-assembly from Berberine and Tannic Acid for Multidrug-resistant Bacteria infection treatment. Pharmaceutics. 2023;15(7):1782. https:\/\/doi.org\/10.3390\/pharmaceutics15071782. Published 2023 Jun 21.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3692_CR54","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3760\/cma.j.cn112150-20230206-00081","volume":"57","author":"FF Zhou","year":"2023","unstructured":"Zhou FF, Gu XM, Wang L, Lin M, Zhonghua. Yu Fang Yi Xue Za Zhi. 2023;57(8):1217\u201321. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20230206-00081","journal-title":"Yu Fang Yi Xue Za Zhi"},{"key":"3692_CR55","doi-asserted-by":"publisher","unstructured":"Zhang Y, Gu Y, Ren H et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11(1):5015. Published 2020 Oct 6. https:\/\/doi.org\/10.1038\/s41467-020-18414-8","DOI":"10.1038\/s41467-020-18414-8"},{"key":"3692_CR56","doi-asserted-by":"publisher","first-page":"644638","DOI":"10.3389\/fphar.2021.644638","volume":"12","author":"Y Tong","year":"2021","unstructured":"Tong Y, Liu L, Wang R, et al. Berberine attenuates chronic Atrophic Gastritis Induced by MNNG and its potential mechanism. Front Pharmacol. 2021;12:644638. https:\/\/doi.org\/10.3389\/fphar.2021.644638. Published 2021 Mar 25.","journal-title":"Front Pharmacol"},{"key":"3692_CR57","doi-asserted-by":"publisher","first-page":"854885","DOI":"10.3389\/fcimb.2022.854885","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang H, Gao Z, Zhang Q, Gu C. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Front Cell Infect Microbiol. 2022;12:854885. https:\/\/doi.org\/10.3389\/fcimb.2022.854885. Published 2022 Aug 25.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03692-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T06:02:23Z","timestamp":1735279343000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03692-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03692-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, isolating MRSA strains from clinical patient samples, adhered to strict ethical guidelines for clinical research. The study strictly followed the <i>Declaration of Helsinki<\/i>, and ethics approval was obtained from the Ethics Committee of Shanghai Eighth People\u2019s Hospital (Approval Number: 2023-058-18). All participating patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author declares no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"540"}}